RecallClass 2 · Action within 48 hours

Class 2 Medicines Recall: Amarox Limited, Sertraline 100mg film-coated tablets, EL(26)A/22

Issued 28 Apr 2026 · EL(26)A/22 · Amarox Limited

Read and act on the official notice on GOV.UK

Class 2 recall — Action within 48 hours. The MHRA uses Class 2 when: The defect may cause mistreatment or harm to the patient, but it is not life-threatening or serious.
What all four recall classes mean
ClassActionThe MHRA's definition
Class 1Immediate actionThe defect presents a risk of death or disability.
Class 2 this recallAction within 48 hoursThe defect may cause mistreatment or harm to the patient, but it is not life-threatening or serious.
Class 3Action within 5 daysThe defect is unlikely to cause harm to the patient.
Class 4Caution in useUsually minor defects in packaging or other printed materials.

A Class 1 recall usually comes with a National Patient Safety Alert. Source: MHRA, safety communications.

The MHRA's summary

Amarox Limited is recalling one batch of Sertraline 100 mg film-coated tablets as a precautionary measure due to an error at the manufacturing site.

Affected batches

As listed by the MHRA, exactly as published. Always check against the GOV.UK notice before acting.

Batch numberExpiryPack sizeFirst distributed
Sertraline 100mg film-coated tablets
V250042505/20282828 November 2025

MHRA's audience tags: Dispensing GP practices, Neurology, Pharmacy, Psychiatry

Pharmshark is not an official alerting route. Make sure your pharmacy receives alerts directly from the MHRA and through your organisation, and always act on the official GOV.UK notice.

Source: the MHRA on GOV.UK. Contains public sector information licensed under the Open Government Licence v3.0. Pharmshark is not affiliated with or endorsed by the MHRA.